In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8(+) T cell responses
原位DC启动的疫苗联合CD137激动剂可通过cDC1介导的肿瘤抗原特异性CD8(+) T细胞反应诱导持久的抗肿瘤免疫。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-011665
Wang, Mengjiao; Qiu, Li; Tang, Cheng; Huang, Danqing; Zheng, Qiaocong; Li, Zunyi; Zhang, Zhenhui; Wei, Shupei; Chen, Lanfang; Huang, Hongxin; Liu, Jun; Zhou, Junfeng; Lu, Tao; Liu, Guanxin; Nie, Yingjie; Leng, Qibin; Chen, Tao
肿瘤
T细胞
肿瘤免疫
CD8
T细胞
细胞生物学
CD13
免疫/内分泌